Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival
![Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose - Kenmotsu - 2015 - Cancer Science - Wiley Online Library Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose - Kenmotsu - 2015 - Cancer Science - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/7fb5b65f-b95f-4179-837e-9495b3f488d1/cas12647-toc-0001-m.jpg?trick=1675798494508)
Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose - Kenmotsu - 2015 - Cancer Science - Wiley Online Library
![Cancers | Free Full-Text | Administering Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer 1–6 Days Compared to More Than 14 Days after the Start of LHRH Agonist Is Associated with Better Clinical Outcomes Cancers | Free Full-Text | Administering Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer 1–6 Days Compared to More Than 14 Days after the Start of LHRH Agonist Is Associated with Better Clinical Outcomes](https://www.mdpi.com/cancers/cancers-14-00864/article_deploy/html/images/cancers-14-00864-g001.png)
Cancers | Free Full-Text | Administering Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer 1–6 Days Compared to More Than 14 Days after the Start of LHRH Agonist Is Associated with Better Clinical Outcomes
![Antitumoral effect and reduced systemic toxicity in mice after intra-tumoral injection of an in vivo solidifying calcium sulfate formulation with docetaxel - ScienceDirect Antitumoral effect and reduced systemic toxicity in mice after intra-tumoral injection of an in vivo solidifying calcium sulfate formulation with docetaxel - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0939641116306683-fx1.jpg)
Antitumoral effect and reduced systemic toxicity in mice after intra-tumoral injection of an in vivo solidifying calcium sulfate formulation with docetaxel - ScienceDirect
![Frontiers | Life-Threatening Docetaxel Toxicity in a Patient With Reduced-Function CYP3A Variants: A Case Report Frontiers | Life-Threatening Docetaxel Toxicity in a Patient With Reduced-Function CYP3A Variants: A Case Report](https://www.frontiersin.org/files/Articles/809527/fonc-11-809527-HTML/image_m/fonc-11-809527-g001.jpg)
Frontiers | Life-Threatening Docetaxel Toxicity in a Patient With Reduced-Function CYP3A Variants: A Case Report
![Processes | Free Full-Text | Docetaxel for Breast Cancer Treatment-Side Effects on Ocular Surface, a Systematic Review Processes | Free Full-Text | Docetaxel for Breast Cancer Treatment-Side Effects on Ocular Surface, a Systematic Review](https://pub.mdpi-res.com/processes/processes-09-01086/article_deploy/html/images/processes-09-01086-g001.png?1624434463)
Processes | Free Full-Text | Docetaxel for Breast Cancer Treatment-Side Effects on Ocular Surface, a Systematic Review
![Network Pharmacology-Based identification of pharmacological mechanism of SQFZ injection in combination with Docetaxel on lung cancer | Scientific Reports Network Pharmacology-Based identification of pharmacological mechanism of SQFZ injection in combination with Docetaxel on lung cancer | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-40954-3/MediaObjects/41598_2019_40954_Fig1_HTML.png)